What AI Still Can’t Translate in Law, Pharma, and Finance

What AI Still Can’t Translate in Law, Pharma, and Finance

Rate this post

The question that keeps coming up

If AI tools can translate contracts, clinical reports, or investor presentations in seconds —
do we still need professional human translators?

It’s a valid question. Especially when procurement teams are promised fast, low-cost results.

But language doesn’t behave like code.
And translation isn’t just about words — it’s about intent, liability, tone, clarity, and cultural precision.

 

Context isn’t optional. It’s operational.

AI operates on prediction. It fills gaps based on patterns.

But in regulated domains — law, pharma, finance — “close enough” isn’t safe enough.

A mistranslated clause can void a contract.
An imprecise dosage instruction can trigger legal exposure or patient risk.

What human translators bring to the table:

  • Contextual judgment across languages
  • Awareness of cultural and jurisdictional differences
  • Control of domain-specific terminology in applied use
  • Professional responsibility for outcomes

They don’t just convert text — they assign meaning with accountability.

 

Traceability matters

You can’t hold a model accountable in court. Or in front of a regulator.

With certified translators — specialists with credentials and revision workflows — you get traceability. You get version control. You get a signature behind the work.

That’s essential when the translation is part of an audit trail, a clinical submission, or a cross-border agreement.

 

Integration, not replacement

Professional translation firms don’t ignore AI. They integrate it — carefully.

Human linguists remain responsible for:

  • Reviewing machine output for critical errors
  • Correcting mismatches in tone or legal intent
  • Aligning terminology with internal glossaries and reference texts
  • Flagging ambiguity before it escalates into liability

Automation supports the workflow. It doesn’t define it.

 

Risk mitigation isn’t optional

If your translation affects a lawsuit, a clinical trial, or a regulatory filing — it’s not content.
It’s evidence.

Good translation isn’t a luxury. It’s operational risk management.
And that’s why real professionals still matter.

Aqueduct TranslationsAuthor posts

Avatar for Aqueduct Translations

CEO & Founder @ Aqueduct Translations SAS | Multi-language vendor of linguistic services

No comment

Leave a Reply

Your email address will not be published. Required fields are marked *